miR-328 Mediates a Metabolic Shift in Colon Cancer Cells by Targeting SLC2A1/GLUT1
Clinical and Translational Oncology - Italy
doi 10.1007/s12094-018-1836-1
Full Text
Open PDFAbstract
Available in full text
Date
January 26, 2018
Authors
Publisher
Springer Science and Business Media LLC